Thanks, these are great points...well I think we're both on the same team of wanting this to do well, but I do agree, I've never been in the camp that this hits $1/share anytime soon...that would be very nice but I consider that highly improbable.
For me, I am fixated on sales growth (rough numbers): $1.7m for 2016, $1.7m for Q12017, 3.3m for Q2 2017, $5m for Q3 2017...until this aggressive rate of growth ends, I think it throws some of the traditional rules of stock valuation out the window. I think as long as it remains profitable, earnings is not as big a focus as sales (as reinvestment of profit into growth is expected). So given the growth above, revenue for 2018 is $20m if they never grow revenue from current levels...but I think its safe to assume revenue will hit $30-$40m...I don't think you'll find another stock of this size and growth (that's profitable) which has forward looking revenue of this sort and has a market cap of $35m...again, look at MJNA...go on OTCMarkets and pull their last quarterly financials...they have a market cap of over $200m (which was recently a bit higher) and help me understand how it is valued so much higher than POTN...
In the SeeThruEquity analysis (though wrong because it calculates PPS on the float shares), it does show comps valued quite a bit higher than POTN (as a multiple of Sales)...
POTN is also blowing away the projections in that analysis.
So while I think there's a 5-10% chance we see $1 PPS within the next 3 - 5 years, I would guess there's a 75% chance we see 12-18 cents in the next 12 months and that's what keeps me in this stock...Also I see a 5% chance that we settle below $.05 in the next year....that's what's allowed me to invest $11k in this stock (more than any stock before) and still sleep like a baby at night.
